New drugs for asthma, allergy and COPD the inside story of drug development

This book provides a state-of-the-art account by academic respiratory physicians and senior pharmaceutical industry personnel on the development of new drugs for asthma, allergy and COPD. It contains 80 chapters of highly condensed information, presented in an attractive, reader-friendly format with...

Full description

Bibliographic Details
Main Author: Hansel, Trevor T. ([Sonstige])
Format: eBook
Language:English
Published: Basel Karger 2001, 2001
Series:Progress in respiratory research
Subjects:
Online Access:
Collection: Karger eBooks Collection 1997-2013 - Collection details see MPG.ReNa
LEADER 02061nmm a2200361 u 4500
001 EB000289227
003 EBX01000000000000000085506
005 00000000000000.0
007 cr|||||||||||||||||||||
008 101101 ||| eng
020 |a 9783805568623 
100 1 |a Hansel, Trevor T.  |e [Sonstige] 
245 0 0 |a New drugs for asthma, allergy and COPD  |h Elektronische Ressource  |b the inside story of drug development  |c vol. eds.: Trevor T. Hansel .. 
260 |a Basel  |b Karger  |c 2001, 2001 
300 |a X + 390 S. 
653 |a (DE-588)4139735-6 / Antiallergikum / gnd 
653 |a Asthma 
653 |a Respiratory System 
653 |a Immunology 
653 |a Internal Medicine 
653 |a (DE-588)4076066-2 / Pharmakotherapie / gnd 
653 |a Allergy 
653 |a Biotechnology 
653 |a Pharmacology 
653 |a (DE-588)4201239-9 / Antiasthmatikum / gnd 
653 |a (DE-588)4213128-5 / Obstruktive Ventilationsstörung / gnd 
041 0 7 |a eng  |2 ISO 639-2 
989 |b ZDB-1-KEB  |a Karger eBooks Collection 1997-2013 
490 0 |a Progress in respiratory research 
776 |z 9783318004243 
856 4 0 |u https://www.karger.com/Book/Home/226823  |x Verlag  |3 Volltext 
082 0 |a 610 
520 |a This book provides a state-of-the-art account by academic respiratory physicians and senior pharmaceutical industry personnel on the development of new drugs for asthma, allergy and COPD. It contains 80 chapters of highly condensed information, presented in an attractive, reader-friendly format with much use of tables, figures and diagrams. In addition to summarizing the diverse range of current approaches, this handbook also looks into the future, considering many topics that are promising, but have only emerged in the last few years. Developments within established drug categories such as beta-2-agonists, steroids and leukotriene antagonists are also reviewed.Never before has a single book brought together so many pharmaceutical drug developers sharing their experience on such a wide range of respiratory topics!